Aarti Drugs Limited (BOM:524348)
India · Delayed Price · Currency is INR 428.35
-8.50 (-1.95%)
At close: Sep 11, 2026
Aarti Drugs Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 26,776 | 25,653 | 23,870 | 25,286 | 27,161 | 24,886 |
Revenue Growth | 10.54% | 7.47% | -5.60% | -6.90% | 9.14% | 15.49% |
Gross Profit Gross Profit Growth | 10,047 | 9,223 | 8,301 | 8,316 | 8,058 | 7,865 |
Operating Income Operating Income Growth | 2,655 | 2,422 | 2,313 | 2,650 | 2,553 | 2,884 |
Net Income Net Income Growth | 1,912 | 1,949 | 1,682 | 1,714 | 1,663 | 2,050 |
Earnings Per Share EPS Growth | 20.95 | 21.36 | 18.35 | 18.65 | 17.96 | 22.14 |
EPS Growth | 1.48% | 16.38% | -1.58% | 3.82% | -18.89% | -26.41% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Out of India Out of India Growth | 9,964 | 8,653 | 8,629 | 10,714 | 9,223 |
India India Growth | 15,689 | 15,217 | 16,657 | 16,446 | 15,663 |
Total Total Growth | 25,653 | 23,870 | 25,286 | 27,161 | 24,886 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 242.8 | 238.33 | 221.43 | 203.2 | 202.89 | 343.81 |
Total Debt Total Debt Growth | 5,766 | 5,766 | 6,151 | 5,643 | 6,089 | 5,428 |
Net Cash (Debt) Net Cash Growth | -5,524 | -5,528 | -5,929 | -5,440 | -5,886 | -5,084 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -60.53 | -60.57 | -64.96 | -59.17 | -63.57 | -54.91 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 2,535 | 2,446 | 3,589 | 1,333 | 704.14 |
Capital Expenditures CapEx Growth | - | -1,733 | -1,772 | -2,263 | -1,648 | -1,520 |
Free Cash Flow Free Cash Flow Growth | - | 802.17 | 674.22 | 1,326 | -314.97 | -815.61 |
Free Cash Flow Growth | - | 18.98% | -49.15% | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 37.52% | 35.95% | 34.77% | 32.89% | 29.67% | 31.60% |
Operating Margin | 9.92% | 9.44% | 9.69% | 10.48% | 9.40% | 11.59% |
Pretax Margin | 8.55% | 8.22% | 8.87% | 9.31% | 8.25% | 10.85% |
Profit Margin | 7.14% | 7.60% | 7.04% | 6.78% | 6.12% | 8.24% |
FCF Margin | - | 3.13% | 2.83% | 5.24% | -1.16% | -3.28% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 | 1.000 | 1.000 | 1.000 | 1.000 |
Dividend Per Share Growth | 100.00% | 100.00% | 0% | 0% | 0% | -60.00% |
Dividend Yield | 0.47% | 0.63% | 0.30% | 0.23% | 0.30% | 0.24% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 20.45 | 14.96 | 18.58 | 23.27 | 18.81 | 19.38 |
Forward PE | 17.29 | 13.58 | 16.62 | 17.30 | 14.25 | 13.79 |
P/FCF Ratio | 48.74 | 36.34 | 46.33 | 30.08 | - | - |
PS Ratio | 1.46 | 1.14 | 1.31 | 1.58 | 1.15 | 1.60 |